-
Berenberg Unimpressed With Pfizer, Initiates Coverage At Hold
Thursday, May 12, 2016 - 5:59pm | 288Read More...Earlier Thursday, Berenberg's Allstair Campbell initiated coverage on Pfizer Inc. (NYSE: PFE) with a Hold rating and set a price target for $38.00. Campbell noted there was "steady if unspectacular growth" inside the company. "We expect Pfizer to deliver mid-single-digit...
-
Tesla's 'True' Gross Margins Are Worse Than What The Company Reports
Wednesday, February 24, 2016 - 11:25am | 402Read More...Tesla Motors Inc (NASDAQ: TSLA) shares are down Wednesday morning, partially on the back of a bearish research note from Germany's Berenberg. Analyst Adam Hull is recommending investors sell the stock on poor gross margins and lowered earnings expectations. The crux of Hull's investment...
-
Sell Tesla On Poor Gross Margin Guidance, Berenberg Warns
Wednesday, February 24, 2016 - 10:57am | 306Read More...Berenberg’s Adam Hull maintained a Sell rating for Tesla Motors Inc (NASDAQ: TSLA), while reducing the price target from $165 to $150. The EPS estimates for 2016 and 2017 have been reduced from $1.50 to $1.00 and from $3.40 to $2.50, respectively. The EPS estimates for 2016-2020 have been...
-
Berenberg Upgrades Bristol-Myers Squibb To Buy, Sees $77 Price Target
Friday, January 22, 2016 - 9:59am | 311Read More...Bristol-Myers Squibb Co (NYSE: BMY) shares are down 7 percent since December 22. Berenberg’s Laura Sutcliffe upgraded the rating for the company from Hold to Buy, while raising the price target from $74 to $77. The company appears well positioned to generate robust growth in the...
-
Berenberg Sees M&A Activity Just Beginning In The Leisure Sector
Thursday, December 10, 2015 - 2:26pm | 569Read More...Stuart Gordon of Berenberg commented on the leisure group, noting the sector remains "ripe" for further consolidation and Marriott International Inc (NASDAQ: MAR)'s acquisition of Starwood Hotels & Resorts Worldwide Inc (NYSE: HOT) is "only the first deal." Gordon cited valuations below...
-
Meet The Disruptors Of The Design Software Industry
Thursday, September 24, 2015 - 5:28pm | 879Read More...Gal Munda of Berenberg argued in a note that "disruptions" within computer-aided design (CAD) and product lifecycle management (PLM) software are already underway. Munda added that "disruptive" companies offer a "real alternative" to legacy PDM and CAD systems. Munda also noted that the barriers...
-
Bayer's Latest Stage 2 Trial Could Be A Boon For Shares
Monday, August 31, 2015 - 3:14pm | 404Read More...Bayer AG (ADR) (OTC: BAYRY) recently finished a mid-stage trial for a heart failure drug, finerenone, which showed a "striking" decline in deaths. Now, a Reuters article informed that the company will move into a final-stage trial before the end of the year. It should be noted, however...
-
Is Shire's $34 Billion Baxalta Acquisition Good For Shareholders? Most Think So
Wednesday, August 5, 2015 - 1:44pm | 595Read More...Shire PLC (ADR) (NASDAQ: SHPG) on Tuesday proposed a combination with Baxalta Inc (NYSE: BXLT) in a $30 billion all-stock deal, implying a potential value of $45.23 per Baxalta share. Here is a roundup of what Wall Street's top analysts are saying. Berenberg: Deal EPS Accretive...
-
Berenberg Upgrades AstraZeneca To Buy
Thursday, July 2, 2015 - 8:51am | 50Read More...Berenberg upgraded AstraZeneca plc (ADR) (NYSE: AZN) from Hold to Buy. AstraZeneca shares have dropped 14.54 percent over the past 52 weeks, while the S&P 500 index has surged 4.63 percent in the same period. AstraZeneca shares jumped 1.44 percent to close at $64.63 yesterday.
-
Greece Is Closer To 'The Abyss,' Warns Berenberg Chief Economist
Wednesday, June 17, 2015 - 5:29pm | 422Read More...Far from the blue waters of Santorini and the mighty power of the ancient European bridge nation, the 2010s have not been a decade for the Greeks. After countless loans from the European Central Bank, the introduction of austerity measures, and what seems like 8 million tonnes of pressure (~7,257,...
-
Morgan Stanley's Positive Comments On Bristol-Myers Squibb
Monday, June 15, 2015 - 4:30pm | 298Read More...In a report published Monday, Morgan Stanley analyst David Risinger and his team reiterated an Overweight rating on Bristol-Myers Squibb Co (NYSE: BMY) after the National Comprehensive Cancer Network (NCCN) updated its guidelines for the treatment of Non-Small Cell Lung Cancer (NSCLC) to...
-
Berenberg Upgrades Telefonica To Hold
Friday, June 12, 2015 - 8:54am | 51Read More...Berenberg upgraded Telefonica S.A. (ADR) (NYSE: TEF) from Sell to Hold. Telefonica shares have dropped 14.13 percent over the past 52 weeks, while the S&P 500 index has surged 8.92 percent in the same period. Telefonica's shares fell 0.69 percent to $14.43 in after-hours trading.
-
Berenberg Downgrades Citrix Systems To Sell
Tuesday, June 9, 2015 - 9:01am | 54Read More...Analysts at Berenberg downgraded Citrix Systems, Inc. (NASDAQ: CTXS) from Buy to Sell. Citrix Systems shares have gained 2.87 percent over the past 52 weeks, while the S&P 500 index has surged 6.59 percent in the same period. Citrix Systems' shares fell 1.80 percent to $64.80 in pre-market...
-
Berenberg Initiates Bristol-Myers Squibb With Hold
Thursday, May 14, 2015 - 9:30am | 63Read More...Berenberg initiated coverage on Bristol-Myers Squibb Co (NYSE: BMY) with a Hold rating. The target price for Bristol-Myers Squibb is set to $70. Bristol-Myers Squibb shares have gained 29.32 percent over the past 52 weeks, while the S&P 500 index has surged 11.12 percent in the same period....
-
Berenberg Initiates Hyster-Yale Materials With Hold
Thursday, April 23, 2015 - 8:49am | 66Read More...Analysts at Berenberg initiated coverage on Hyster-Yale Materials Handling Inc (NYSE: HY) with a Hold rating. The target price for Hyster-Yale Materials is set to $80.90. Hyster-Yale Materials shares have dropped 26.17 percent over the past 52 weeks, while the S&P 500 index has surged 12.21...
